Propionylcarnitine

Propionylcarnitine is a lipid of Fatty Acyls (FA) class. Propionylcarnitine is associated with abnormalities such as Failure to Thrive. The involved functions are known as Functional disorder. Propionylcarnitine often locates in Body tissue.

Cross Reference

Introduction

To understand associated biological information of Propionylcarnitine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Propionylcarnitine?

Propionylcarnitine is suspected in Failure to Thrive and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Propionylcarnitine

MeSH term MeSH ID Detail
Penile Induration D010411 4 associated lipids
Amino Acid Metabolism, Inborn Errors D000592 16 associated lipids
Erectile Dysfunction D007172 19 associated lipids
Pregnancy Complications D011248 19 associated lipids
Metabolism, Inborn Errors D008661 46 associated lipids
Starvation D013217 47 associated lipids
Reperfusion Injury D015427 65 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Body Weight D001835 333 associated lipids
Total 10

PubChem Associated disorders and diseases

What pathways are associated with Propionylcarnitine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Propionylcarnitine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Propionylcarnitine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Propionylcarnitine?

There are no associated biomedical information in the current reference collection.

What genes are associated with Propionylcarnitine?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with Propionylcarnitine?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Propionylcarnitine

Download all related citations
Per page 10 20 50 100 | Total 223
Authors Title Published Journal PubMed Link
Mister M et al. Propionyl-L-carnitine prevents renal function deterioration due to ischemia/reperfusion. 2002 Kidney Int. pmid:11849462
Azzollini N et al. Propionyl-L-carnitine prevents early graft dysfunction in allogeneic rat kidney transplantation. 2008 Kidney Int. pmid:19008910
Signorelli SS et al. Propionyl-L-carnitine therapy: effects on endothelin-1 and homocysteine levels in patients with peripheral arterial disease and end-stage renal disease. 2006 Kidney Blood Press. Res. pmid:16809937
Sarafoglou K et al. Expanded newborn screening for detection of vitamin B12 deficiency. 2011 JAMA pmid:21427371
Cipolla MJ et al. Propionyl-L-carnitine dilates human subcutaneous arteries through an endothelium-dependent mechanism. 1999 J. Vasc. Surg. pmid:10359944
Loffredo L et al. Imbalance between nitric oxide generation and oxidative stress in patients with peripheral arterial disease: effect of an antioxidant treatment. 2006 J. Vasc. Surg. pmid:16950429
Alvarez de Sotomayor M et al. Effect of L-carnitine and propionyl-L-carnitine on endothelial function of small mesenteric arteries from SHR. 2007 J. Vasc. Res. pmid:17483601
Safarinejad MR et al. Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie's disease: a double-blind, placebo controlled, randomized study. 2007 J. Urol. pmid:17706714
Cunningham VJ et al. Uptake of [N-methyl-11C]propionyl-L-carnitine (PLC) in human myocardium. 1996 J. Pharmacol. Exp. Ther. pmid:8613961
Hotta N et al. Effect of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: comparison with an aldose reductase inhibitor. 1996 J. Pharmacol. Exp. Ther. pmid:8558455
Wu X et al. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. 1999 J. Pharmacol. Exp. Ther. pmid:10454528
Mancinelli A et al. Uptake of L-carnitine and its short-chain ester propionyl-L-carnitine in the isolated perfused rat liver. 2005 J. Pharmacol. Exp. Ther. pmid:15951397
Marble M et al. Neonatal vitamin B12 deficiency secondary to maternal subclinical pernicious anemia: identification by expanded newborn screening. 2008 J. Pediatr. pmid:18410783
Bogusiewicz A et al. In HepG2 cells, coexisting carnitine deficiency masks important indicators of marginal biotin deficiency. 2015 J. Nutr. pmid:25527659
Brass EP and Ruff LJ Effect of carnitine on propionate metabolism in the vitamin B-12--deficient rat. 1989 J. Nutr. pmid:2778544
Perna AF et al. L-Propionyl carnitine, homocysteine and S-adenosylhomocysteine in hemodialysis. 2007 Jan-Feb J. Nephrol. pmid:17347975
Broderick TL et al. L-propionylcarnitine enhancement of substrate oxidation and mitochondrial respiration in the diabetic rat heart. 1996 J. Mol. Cell. Cardiol. pmid:8729065
Kotaka K et al. Reversal of ischemia-induced mitochondrial dysfunction after coronary reperfusion. 1982 J. Mol. Cell. Cardiol. pmid:7108975
Ferrari R et al. Prolonged propionyl-L-carnitine pre-treatment of rabbit: biochemical, hemodynamic and electrophysiological effects on myocardium. 1992 J. Mol. Cell. Cardiol. pmid:1625347
Huemer M et al. Newborn screening for homocystinurias and methylation disorders: systematic review and proposed guidelines. 2015 J. Inherit. Metab. Dis. pmid:25762406
Shigematsu Y et al. Useful second-tier tests in expanded newborn screening of isovaleric acidemia and methylmalonic aciduria. 2010 J. Inherit. Metab. Dis. pmid:20440648
Kuster T et al. Filter paper cards contaminated with EMLA cream produce artefacts on acylcarnitine analysis. 2004 J. Inherit. Metab. Dis. pmid:15669691
Kuhara T et al. Gas chromatographic-mass spectrometric newborn screening for propionic acidaemia by targeting methylcitrate in dried filter-paper urine samples. 2002 J. Inherit. Metab. Dis. pmid:12118533
Wang F et al. Clinical, biochemical, and molecular analysis of combined methylmalonic acidemia and hyperhomocysteinemia (cblC type) in China. 2010 J. Inherit. Metab. Dis. pmid:20924684
Hailemariam D et al. Identification of predictive biomarkers of disease state in transition dairy cows. 2014 J. Dairy Sci. pmid:24630653
Roe CR et al. L-carnitine enhances excretion of propionyl coenzyme A as propionylcarnitine in propionic acidemia. 1984 J. Clin. Invest. pmid:6725560
Hasegawa Y et al. Prenatal diagnosis for organic acid disorders using two mass spectrometric methods, gas chromatography mass spectrometry and tandem mass spectrometry. 2005 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:15908288
Delgado C et al. Subacute presentation of propionic acidemia. 2007 J. Child Neurol. pmid:18174561
Torielli L et al. Alterations in energy metabolism of hypertrophied rat cardiomyocytes: influence of propionyl-L-carnitine. 1995 J. Cardiovasc. Pharmacol. pmid:8583777
Micheletti R et al. Effect of propionyl-L-carnitine on the mechanics of right and left papillary muscles from volume-overloaded rat hearts. 1996 J. Cardiovasc. Pharmacol. pmid:8656658
Duncker DJ et al. L-propionylcarnitine does not affect myocardial metabolic or functional response to chronotropic and inotropic stimulation after repetitive ischemia in anesthetized pigs. 1993 J. Cardiovasc. Pharmacol. pmid:7504143
Orlandi A et al. Propionyl-L-carnitine prevents age-related myocardial remodeling in the rabbit. 2007 J. Cardiovasc. Pharmacol. pmid:17703133
Aomine M et al. Electrophysiologic effects of a short-chain acyl carnitine, L-propionylcarnitine, on isolated canine Purkinje fibers. 1989 J. Cardiovasc. Pharmacol. pmid:2471897
Bartels GL et al. Acute improvement of cardiac function with intravenous L-propionylcarnitine in humans. 1992 J. Cardiovasc. Pharmacol. pmid:1383625
Yang XP et al. Hemodynamic and metabolic activities of propionyl-L-carnitine in rats with pressure-overload cardiac hypertrophy. 1992 J. Cardiovasc. Pharmacol. pmid:1383636
Ferrari R and De Giuli F The propionyl-L-carnitine hypothesis: an alternative approach to treating heart failure. 1997 J. Card. Fail. pmid:9330130
Forny P et al. Novel Mouse Models of Methylmalonic Aciduria Recapitulate Phenotypic Traits with a Genetic Dosage Effect. 2016 J. Biol. Chem. pmid:27519416
Ganapathy ME et al. beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter. 2000 J. Biol. Chem. pmid:10636865
Orlandi A et al. Propionyl-L-carnitine reduces proliferation and potentiates Bax-related apoptosis of aortic intimal smooth muscle cells by modulating nuclear factor-kappaB activity. 2007 J. Biol. Chem. pmid:17178728
Brass EP et al. Carnitine delays rat skeletal muscle fatigue in vitro. 1993 J. Appl. Physiol. pmid:8282608
Leipälä JA et al. Protection of the reperfused heart by L-propionylcarnitine. 1991 J. Appl. Physiol. pmid:1757378
Brevetti G et al. Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study. 1995 J. Am. Coll. Cardiol. pmid:7594063
Brevetti G et al. European multicenter study on propionyl-L-carnitine in intermittent claudication. 1999 J. Am. Coll. Cardiol. pmid:10551714
Serjeant BE et al. Propionyl-L-carnitine in chronic leg ulcers of homozygous sickle cell disease: a pilot study. 1997 J. Am. Acad. Dermatol. pmid:9308570
De Maria P et al. Effect of the addition of electrolytes on the partition coefficients, activity coefficients, and acid dissociation constants of carnitine and its acetyl and propionyl derivatives. 1994 J Pharm Sci pmid:8071833
D'Acquarica I et al. Enantio- and chemo-selective HPLC separations by chiral-achiral tandem-columns approach: the combination of CHIROBIOTIC TAG and SCX columns for the analysis of propionyl carnitine and related impurities. 2004 J Chromatogr A pmid:15641359
Cheng KH et al. Newborn screening for methylmalonic aciduria by tandem mass spectrometry: 7 years' experience from two centers in Taiwan. 2010 J Chin Med Assoc pmid:20603089
Kendler BS Supplemental conditionally essential nutrients in cardiovascular disease therapy. 2006 Jan-Feb J Cardiovasc Nurs pmid:16407731
Hiatt WR et al. Effect of propionyl-L-carnitine on a background of monitored exercise in patients with claudication secondary to peripheral artery disease. 2011 Mar-Apr J Cardiopulm Rehabil Prev pmid:20861750
Tang YM et al. Urine and serum metabolomic profiling reveals that bile acids and carnitine may be potential biomarkers of primary biliary cirrhosis. 2015 Int. J. Mol. Med. pmid:26046127